COMPANY PROFILE

Reliable Med

Explore full profile

Hangzhou, ChinaFounded 2019Hard Tech

Valuation $50–100M Last recorded · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2019
Headquarters: Hangzhou, China
Employees: 2
Open positions: 10
Dealroom signal: 20.7/100
Sector: Hard Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Feb 2023	$14M	$55M	Su xin Venture Capital · Industrial Securities · Industrial Securities Capital	↗
SEED✓Equity / VC	Apr 2022	—	—	Legend Capital	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Reliable Med website traffic

Latest recorded traffic for Reliable Med is 150 monthly website visits, down 64.3% over the last three months. Reliable Med's team grew 100% over the past year.

Latest monthly visits150 3-month web change-64.3% 1-year team growth+100%

Monthly website visitsFeb 2023–Dec 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

(J10036)Guangzhou, Guangdong, China · Other · Jun 20, 2026 +(J10084)Guangzhou, Guangdong, China · Other · Jun 13, 2026 (J10094)Beijing, Beijing, China · Other · Jun 12, 2026

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
KIKaliVir ImmunotherapeuticsDevelops oncolytic viral immunotherapy programs for the treatment of cancer	O'Hara Township, United States	Operational	29	$29M	$56M
WCWeavr Health CorpDeveloped easy-to-use, reliable blood collection devices to ensure anyone, anywhere can access the best health and wellness care	Cambridge, United States	Closed
MTMimosa TherapeuticsOffering research-grade natural psilocybin and drug potency test kits	United States	Operational
DODuo OncologyDeveloping a new nanoparticle technology specially tailored to penetrate established tumors	Pittsburgh, United States	Operational
L3LUMINELLE 360An innovative femtech solution offering convenient, cost-effective office Hysteroscopy and Cystoscopy procedures	Raleigh, United States	Acquired
NMNovel MicrodevicesNOVEL DX - Point-Of-Care Molecular Diagnostics	Baltimore, United States	Operational
BRBrinterWe are fundamentally shifting global Health Care with our 3D (bio)printing applications	Winston-Salem, United States	Operational
NINanoTess Inc.Revolutionizing nanotechnology that solves the world's toughest health challenges beginning with chronic wounds	Calgary, Canada	Operational